Ex-ante priority setting in crop breeding: Towards inclusive innovation for impact

Autor: Occelli, M., Compaore, E., Brown, D., Barry, F., Poda, L.S., Traore, F., Waongo, A., Rubin, D., Tufan, H.A.

Publikováno v: In Agricultural Systems May 2024 217

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study

Autor: Guida, M., Strippoli, S., Maule, M., Quaglino, P., Ramondetta, A., Chiaron Sileni, V., Antonini Cappellini, G., Queirolo, P., Ridolfi, L., Del Vecchio, M., Cocorocchio, E., Di Giacomo, A.M., Festino, L., Merelli, B., Occelli, M., Brugnara, S., Minisini, A., Sava, S., Tommasi, S., De Summa, S.

Publikováno v: In ESMO Open April 2021 6(2)

LR B-Splines implementation in the Altair RadiossTM solver for explicit dynamics IsoGeometric Analysis

Autor: Occelli, M., Elguedj, T., Bouabdallah, S., Morançay, L.

Publikováno v: In Advances in Engineering Software May 2019 131:166-185

Expanded Clays and Other Microporous Solids. [elektronicky zdroj]

Autor: Occelli, M. L.

Externí odkaz: Kolekce e-knih KNAV (Registrovani uzivatele: plny text online 5 minut, dalsi pristup na vyzadani. Registered users: full text online 5 minutes, further access on requests.)

Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.

Autor: Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy. Electronic address: mario.mandala@unipg.it., Lorigan P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Sergi MC; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy., Benannoune N; Gustave Roussy Cancer Campus, Villejuif, France., Serra P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy., Giannarelli D; Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Arance AM; Hospital Clínic Barcelona, 08036 Barcelona, Spain., Couselo EM; Department of Medical Oncology. Vall d'Hebron Hospital, Barcelona, Spain & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Neyns B; Department of Medical Oncology, UZ Brussel, Brussels, Belgium., Tucci M; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II,' Bari, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy., Rossi E; Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Occelli M; Medical Oncology, AO S.Croce e Carle, Cuneo, Italy., Queirolo P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Quaglino P; Department of Dermatology, University of Turin, Turin, Italy., Depenni R; University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy., Merelli B; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Indini A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., da Silva IP; Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113542. Date of Electronic Publication: 2024 Jan 19.